1465 / 1835
time since chemotherapy start, months
median follow-up 6 years
OS
in PRs
87%
median follow-up 6 years
EORTC H34 Trial 1988-2001
PR
IF RT 30Gy Survival (n= 250)
(250)
(68)
(88)
Aleman
et al., NEJM
2003; 348:2396-406
|
|
1465 / 1835
time since chemotherapy start, months
median follow-up 6 years
OS
in PRs
87%
median follow-up 6 years
EORTC H34 Trial 1988-2001
PR
IF RT 30Gy Survival (n= 250)
(250)
(68)
(88)
Aleman
et al., NEJM
2003; 348:2396-406